Tech Launch Arizona StartupHub facilitates connections for venture-ready inventors seeking qualified co-founders.Continue reading
Category Archives: AZBio News
ASU research finds link between removal of uterus, brain function
A growing body of research is revealing that the uterus is more of a powerhouse organ than previously thought, with connections to the immune system and heart. Now, scientists from Arizona State University have added to this evidence with their recent finding that the uterus — and its removal — may have a direct impact on brain function.Continue reading
Scripps Research Scientists, TGen Scientists Uncover New Molecular Drivers of Alzheimer’s
By recording detailed electrical and protein measurements of individual brain cells, researchers revealed new potential drug targets for the neurodegenerative disease
Barrow Neurological Institute expands Phoenix research footprint with the opening of new neuro analytics center
Barrow Neurological Institute has opened a new cutting-edge research center that is expected to revolutionize neurological research and expand Phoenix’s research footprint into the areas of environmental neurology and health equity.Continue reading
Arizona Bioindustry Association Earns Candid’s Platinum Seal Of Transparency for 2024
The Platinum Seal is the highest level of recognition offered by Candid (formerly known as GuideStar) and is awarded to organizations that meet the highest standards of transparency and accountability.Continue reading
AZBioPEERS: Strategies to Attract, Develop and Retain Talent
Join us for a video replay of this insightful discussion on talent management strategies, featuring an esteemed panel with diverse experience.Continue reading
The Foundation for the National Institutes of Health Announces the Launch of a Public-Private Partnership to Accelerate ALS Diagnosis and Treatment
- The Foundation for the National Institutes of Health Announces the Launch of a Public-Private Partnership to Accelerate ALS Diagnosis and Treatment
- The Accelerating Medicines Partnership® in Amyotrophic Lateral Sclerosis (AMP® ALS) will create the largest open data platform for ALS research
- Partnership will enable discovery and development of diagnostic tools, biomarkers, and better treatments
Managed by the FNIH, the Accelerating Medicines Partnership® in Amyotrophic Lateral Sclerosis (AMP® ALS) brings together the resources and expertise of the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health (NIH), the Food and Drug Administration (FDA), Critical Path Institute (C-Path), and other stakeholders from academia, life science companies, foundations, and patient-focused groups to tackle the tremendous challenges of diagnosing, understanding, and treating the disease. AMP ALS is supported by a combined commitment of approximately $60 million.Continue reading
C-Path’s TRxA Announces its First Biologics-focused RFP for Academic Investigators
NEW FUNDING OPPORTUNITY!
Nectero Medical Announces Completion of $96M Series D Financing
The proceeds will support the execution of the Phase II/III trial and potential NDA submission for the Nectero EAST System, a Breakthrough Therapy for small to medium-sized AAA.Continue reading
Accelerate Diagnostics Announces 510(k) Submission of the Accelerate Arc™ System to the FDA
Enabling rapid, automated microbial identification directly from positive blood culture samplesContinue reading